Markus Warmuth, President & CEO at Monte Rosa Therapeutics, Inc. (GLUE), sold 10,932 shares at $23.24 ($257K) on 2026-01-07, disclosed to the SEC on 2026-01-09.
Open-market sale of $257k GLUE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.24 | 3,707 | $86K | 33.6% |
| 2 | $23.24 | 3,707 | $86K | 33.6% |
| 3 | $23.88 | 1,450 | $35K | 13.5% |
| 4 | $23.88 | 1,450 | $35K | 13.5% |
| 5 | $24.57 | 309 | $8K | 3.0% |
| 6 | $24.57 | 309 |
| $8K |
| 3.0% |
| Total | $23.49 avg | 10,932 | $257K | 100% |
| Filing → |
| GLUE | SELL | 2026-05-05 | $103K | — | Filing → |
| GLUE | SELL | 2026-04-15 | $141K | — | Filing → |
| GLUE | SELL | 2026-03-04 | $98K | — | Filing → |